News
13h
GlobalData on MSNCullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trialThe trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.
Early detection is crucial, as it helps manage symptoms effectively and prevent long-term joint damage. Read on to find out ...
Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other ...
1d
Everyday Health on MSNPsoriasis and Rheumatoid Arthritis: Are You at Risk?Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.
Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
A major Medicare study shows that while long-term steroid use declines after diagnosis of late-onset rheumatoid arthritis, a ...
3d
PsyPost on MSNChildhood maltreatment linked to higher risk of rheumatoid arthritis and psoriasis, study findsA new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...
A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...
The Rheumatology Therapeutics market revenue was $$ Million USD in 2022, grew to $$ Million USD in 2024, and will reach $$ Million USD in 2032, with a CAGR of $% during 2024-2032.
April is Sjogren’s Disease Awareness MonthPeople with Sjogren's live with a high burden of disease; on average their quality ...
Learn how breathing strategies and cold immersion techniques developed by Wim Hof directly impact the autonomic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results